Dear GRG Member,
This just in from PR Newswire
Calico and QB3 announce partnership to conduct research into the biology of aging and to identify potential therapeutics for age-related diseases.
QB3’s mission is to stimulate innovative life science to keep us healthy, sustain our environment and grow the economy. Mission page: http://ift.tt/1HxTqon
– The objective of the four-year partnership is to make discoveries that will translate into a better understanding of the biology of aging and potential therapies for age-related diseases.
– With committed funding from Calico, the partnership will identify, fund and support QB3 research projects focused on aging.
– Partnership has two synergistic components:
o broad sponsored research agreement to enable collaboration between Calico and multiple QB3 laboratories on specific research programs related to aging,
o grant mechanism to support innovation in longevity research led by QB3. Calico has the option to obtain exclusive rights to discoveries made under the sponsored research agreement.
John M. “Johnny” Adams
Executive Director Gerontology Research Group
(949) 922-9786 cell
CEO / Exec. Director
Carl I. Bourhenne Medical Research Foundation / Aging Intervention Foundation